Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason

  • The Health Care Select Sector SPDR Fund XLV, heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies reporting annual earnings.
  • Shares of Health Care Select Sector SPDR Fund opened at $129.26 on Monday, with a twelve-month low of $118.75 and a twelve-month high of $143.42. YTD shares lost 6.54%.
  • Top holding companies Merck & Co Inc MRKAbbVie Inc ABBV, Eli Lilly And Co LLYThermo Fisher Scientific Inc TMOAbbott Laboratories ABT, and Bristol Meyers Squibb & Co BMY reported their Q4 earnings during the month.
  • Over the month, Lilly stock lost 5.5%, Thermo Fisher fell 2.45%, Abbott lost 6.54%, Bristol Myers slipped 7.2%, while Merck shares gained 6.28%, and AbbVie jumped 7.2%. 
  • Over one month, iShares Biotechnology ETF IBB shares have fallen 4.3%, with stock opening at $130.27.
  • Today, Aclaris Therapeutics Inc ACRS was retreating nearly 40% after zunsemetinib did not meet its primary and secondary efficacy endpoints
  • Adaptimmune Therapeutics Inc ADAP and TCR2 Therapeutics Inc TCRR agreed to merge
  • TCR2 was rising over 25% in value, while Adaptimmune Therapeutics was down more than 20%.
  • BridgeBio Pharma Inc BBIO shares are gaining over 50% after positive data from the PROPEL2 Phase 2 trial of infigratinib in the form of dwarfism.
  • Price Action: XLV shares closed down 1.60% at $127.04, and IBB closed down 1.59% at $127.25 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechNewsPenny StocksSector ETFsHealth CareSmall CapMoversETFsGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!